Pregabalin & Heart Failure Risk: Older Adults Study
Pregabalin Linked to Increased Heart Failure Risk in Older Adults: Study Highlights Need for Caution
A recent study published in [Insert Journal Name Hear, if known, or else omit] has revealed a concerning link between pregabalin (Lyrica) use and an increased risk of heart failure (HF) in older adults with chronic pain.The research, which analyzed data from over 246,000 Medicare beneficiaries, suggests that initiating pregabalin may pose a greater risk of developing HF compared to gabapentin (Neurontin), especially in individuals with pre-existing cardiovascular disease (CVD).
chronic pain is a widespread issue among older adults, often managed with medications like gabapentin and pregabalin. Both drugs are commonly prescribed for neuropathic pain, back pain, and musculoskeletal pain. However, this new study raises important questions about the cardiovascular safety of pregabalin in this vulnerable population.
Study Details and Key Findings
The study focused on Medicare beneficiaries aged 65 and older with a chronic pain diagnosis who were newly prescribed either gabapentin or pregabalin. Researchers excluded individuals with pre-existing heart failure, terminal illnesses, or recent hospitalizations to isolate the impact of the medications. The participants were followed until they experienced an emergency department visit or hospitalization for heart failure, death, or the end of the study period.
The results indicated that pregabalin was associated with a higher risk of heart failure compared to gabapentin. Specifically, the incidence of heart failure per 1,000 person-years was 18.2 for pregabalin users compared to 12.5 for gabapentin users. This increased risk was particularly pronounced in women, White individuals, and those with a history of cardiovascular disease. The study also found a significantly higher risk of outpatient heart failure among pregabalin users.
Why This Matters: Implications for Prescribing Practices
These findings underscore the importance of careful consideration when prescribing pregabalin to older adults, especially those with pre-existing heart conditions. While both gabapentin and pregabalin can be effective for managing chronic pain,the potential for increased heart failure risk with pregabalin warrants a thorough risk-benefit assessment.
“Clinicians should carefully assess ongoing cardiovascular risk factors and provide adequate risk-benefit counseling to older people before prescribing pregabalin for chronic pain,” the study authors emphasized. This includes discussing alternative pain management strategies and closely monitoring patients for any signs or symptoms of heart failure after initiating pregabalin.
Limitations and Future Research
The study authors acknowledge several limitations, including a sample skewed towards female and White individuals, the exclusion of Medicare Advantage enrollees, and the lack of data on certain lifestyle factors like body mass index, smoking, and physical activity. Further research is needed to confirm these findings in more diverse populations and to explore the underlying mechanisms by which pregabalin may contribute to heart failure risk.
The Bottom Line
This study provides valuable insights into the potential cardiovascular risks associated with pregabalin use in older adults with chronic pain.While pregabalin remains a valuable tool for pain management, clinicians should exercise caution when prescribing it to older individuals, particularly those with pre-existing heart conditions. A thorough risk-benefit assessment, careful patient monitoring, and open interaction about potential risks are crucial to ensuring the safety and well-being of this vulnerable population.